Literature DB >> 11932670

Recurrence of chronic venous ulcers on the basis of clinical, etiologic, anatomic, and pathophysiologic criteria and air plethysmography.

Huey B McDaniel1, William A Marston, Mark A Farber, Robert R Mendes, Lewis V Owens, Mary L Young, Patty F Daniel, Blair A Keagy.   

Abstract

INTRODUCTION: Leg ulcers associated with chronic venous insufficiency (CVI) frequently recur after healing. The risk of recurrence has not been well defined for patients in different anatomic and hemodynamic groups. We reviewed the risk of ulcer recurrence on the basis of clinical, etiologic, anatomic, and pathophysiologic criteria and hemodynamic characteristics of the affected limb as assessed with air plethysmography (APG).
METHODS: Ninety-nine limbs with class 6 CVI were assessed clinically and with standing duplex ultrasound scanning and APG for the definition of clinical, etiologic, anatomic, and pathophysiologic criteria. Leg ulcers were treated with high-pressure compression protocols. Surgical correction of venous abnormalities was offered to patients with appropriate conditions. After ulcer healing, the limbs were placed in compressive garments and followed at 6-month intervals for ulcer recurrence.
RESULTS: The mean patient age was 54.3 years, and 46% of the patients were female. Corrective venous surgery was performed in 37 limbs. The mean follow-up time for all 99 limbs was 28 months. The ulcer recurrence rate with life table was 37% +/- 6% at 3 years and 48% +/- 10% at 5 years. The patients who underwent venous surgery had a significantly lower recurrence rate (27% +/- 9% at 48 months) than did those patients who had not undergone surgery (67% +/- 8% at 48 months; P =.005). The patients with deep venous insufficiency (DVI; n = 51) had significantly higher recurrence rates (66% +/- 8% at 48 months) than did the patients without DVI (n = 48; 29% +/- 9% at 48 months; P =.006). This difference was significant even after accounting for the effects of surgery (P =.03). The hazard ratio of ulcer recurrence increases by 14% for every unit increase in the venous filling index (VFI; P =.001). This remains significant even after accounting for the effects of surgery (P =.001). The combination of DVI and a VFI of more than 4 mL/s yields a risk of ulcer recurrence of 43% +/- 9% at 1 year and 60% +/- 10% at 2 years.
CONCLUSION: Leg ulcers associated with CVI have a high rate of recurrence. Ulcer recurrence is significantly increased in patients with DVI and in patients who do not have venous abnormalities corrected surgically. The VFI obtained from APG is useful in the prediction of increased risk for recurrence, particularly in association with anatomic data.

Entities:  

Mesh:

Year:  2002        PMID: 11932670     DOI: 10.1067/mva.2002.121128

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  18 in total

1.  [Surgical therapy of venous leg ulcers].

Authors:  T M Proebstle
Journal:  Hautarzt       Date:  2003-03-11       Impact factor: 0.751

2.  Nutritional profile of older adults with chronic venous leg ulcers: a pilot study.

Authors:  Jodi C McDaniel; Kaitlyn G Kemmner; Sarah Rusnak
Journal:  Geriatr Nurs       Date:  2015-07-02       Impact factor: 2.361

3.  Predicting the likelihood of venous leg ulcer recurrence: The diagnostic accuracy of a newly developed risk assessment tool.

Authors:  Kathleen J Finlayson; Christina N Parker; Charne Miller; Michelle Gibb; Suzanne Kapp; Rajna Ogrin; Jacinta Anderson; Kerrie Coleman; Dianne Smith; Helen E Edwards
Journal:  Int Wound J       Date:  2018-03-13       Impact factor: 3.315

4.  Subfascial endoscopic perforator surgery (SEPS) for treating venous leg ulcers.

Authors:  Zhiliang Caleb Lin; Paula M Loveland; Renea V Johnston; Michael Bruce; Carolina D Weller
Journal:  Cochrane Database Syst Rev       Date:  2019-03-03

5.  Deep venous external valvuloplasty using a rigid angioscope.

Authors:  Hiroyoshi Komai; Masanobu Juri
Journal:  Surg Today       Date:  2010-05-23       Impact factor: 2.549

Review 6.  Preventing venous ulcer recurrence: a review.

Authors:  Kathryn R Vowden; Peter Vowden
Journal:  Int Wound J       Date:  2006-03       Impact factor: 3.315

7.  Effect of oxidised regenerated cellulose/collagen matrix on proteases in wound exudate of patients with chronic venous ulceration.

Authors:  Ralf Smeets; Dietmar Ulrich; Frank Unglaub; Michael Wöltje; Norbert Pallua
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

8.  Encouraging patients to self-care - the preliminary development and validation of the VeLUSET©, a self-efficacy tool for venous leg ulcer patients, aged 60 years and over.

Authors:  Annemarie Brown; Sally Kendall; Madeleine Flanagan; Michaela Cottee
Journal:  Int Wound J       Date:  2013-12-26       Impact factor: 3.315

9.  Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2019-02-19

10.  A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix® ) allograft for the treatment of venous leg ulcers.

Authors:  Christian Bianchi; Shawn Cazzell; Dean Vayser; Alexander M Reyzelman; Hasan Dosluoglu; Gregory Tovmassian
Journal:  Int Wound J       Date:  2017-10-11       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.